12th International Congress on Myeloproliferative Neoplasms

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

12th International Congress on Myeloproliferative Neoplasms

Latest Advances in Myeloproliferative Neoplasms
Cases
Event

Playback speed

10 seconds

What is the Molecular Landscape of Blast Phase MPN and the Implications for Targeted Therapeutic Approaches?

By 12th International Congress on Myeloproliferative Neoplasms FEATURING Olatoyosi Odenike

17 views

November 12, 2019

Comments 0

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba

Latest Advances in Myeloproliferative Neoplasms

19:58

12th International Congress on Myeloproliferative Neoplasms

How Should We Treat Children w/ MPN: No Guidelines on Cytoreduction …

Feat. N. Kucine

Old and New Myelofibrosis (MF) Classifications, When to Consider Tra…

12th International Congress on Myeloproliferative Neoplasms

H. Deeg

34 views

Introduction to Hypoxia and Erythropoiesis in the Context of High Al…

12th International Congress on Myeloproliferative Neoplasms

J. Prchal

32 views

Moving Beyond JAKi: Ruxolitinib Failure, Newly Approved and in Devel…

12th International Congress on Myeloproliferative Neoplasms

N. Pemmaraju

114 views

Is There a Role of Transplantation for CML in the Era of TKIs?

12th International Congress on Myeloproliferative Neoplasms

K. Van Besien

21 views

What Are the Risk Factors for Accelerated/Blast Phase MPN and the Ou…

12th International Congress on Myeloproliferative Neoplasms

O. Odenike

19 views

What is the Molecular Landscape of Blast Phase MPN and the Implicati…

12th International Congress on Myeloproliferative Neoplasms

O. Odenike

17 views

Targeting Dysregulated Iron Metabolism in Polycythemia Vera (PV) Pat…

12th International Congress on Myeloproliferative Neoplasms

R. Hoffman

17 views

Therapeutic Options for Treating MPNs are Finally Expanding: Targeti…

12th International Congress on Myeloproliferative Neoplasms

R. Hoffman

164 views

Therapeutic Options for MPNs are Finally Expanding: Immunotherapies …

12th International Congress on Myeloproliferative Neoplasms

R. Hoffman

21 views

Interferon in Polycythemia Vera (PV) Yields Improved Myelofibrosis-F…

12th International Congress on Myeloproliferative Neoplasms

R. Silver

22 views

Update on Long Acting Interferons in MPN: Who Should Be Treated, Who…

12th International Congress on Myeloproliferative Neoplasms

H. Gisslinger

23 views

Wrangling the MPN-Related Symptom Burden: Specific Symptoms and Etio…

12th International Congress on Myeloproliferative Neoplasms

R. Scherber

169 views

Update on Myeloid Variant Hypereosinophilia Syndrome: Clinical Subty…

12th International Congress on Myeloproliferative Neoplasms

A. Klion

34 views

Tales from the Clinic on Essential Thrombocytosis: No Therapy for As…

12th International Congress on Myeloproliferative Neoplasms

J. Spivak

51 views

Review of JAK2V617F and the Concept of the VAF

12th International Congress on Myeloproliferative Neoplasms

A. Moliterno

21 views

Review of JAK2V617F VAF Associations in the Context of MPN and CHIP:…

12th International Congress on Myeloproliferative Neoplasms

A. Moliterno

24 views